Marcos A. Carvalho

The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas

Fabiana Seguin, Marcos A. Carvalho, Débora Campanella Bastos et al. · British Journal of Cancer · 2012 · 158 citations · Full text

Medicine, Oncology, Pharmacology +17

A silver complex with tryptophan: Synthesis, structural characterization, DFT studies and antibacterial and antitumor assays in vitro

Marcos A. Carvalho, Raphael Enoque Ferraz de Paiva, Fernando R.G. Bergamini et al. · Journal of Molecular Structure · 2012 · 42 citations

Natural Sciences, Biochemistry, Chemistry +9

Enhanced performance of a metal-organic framework analogue to MIL-101(Cr) containing amine groups for ibuprofen and nimesulide controlled release

Irlene M.P. Silva, Marcos A. Carvalho, Cintia S. Oliveira et al. · Inorganic Chemistry Communications · 2016 · 28 citations

Pharmacy, Medicinal Chemistry, Pharmaceutics +12

Synthesis, spectroscopic characterization, DFT studies, and initial antibacterial assays <i>in vitro</i> of a new palladium(II) complex with tryptophan

Marcos A. Carvalho, Bárbara Camila de Araújo Souza, Raphael Enoque Ferraz de Paiva et al. · Journal of Coordination Chemistry · 2012 · 26 citations

Natural Sciences, Chemistry, Medicinal Chemistry +16

Polynuclear copper(II) complexes with nalidixic acid hydrazones: Antiproliferative activity and selectivity assessment over a panel of tumor cells

Fernando R.G. Bergamini, Julia H. Bormio Nunes, Marcos A. Carvalho et al. · Inorganica Chimica Acta · 2018 · 26 citations · Full text

Natural Sciences, Chemistry, Medicinal Chemistry +11